Featured Portfolio
Surgical AI makes healthcare decisions simpler and more efficient. It uses past evidence, understands data, and explains treatment decisions clearly. Plus, it fits into hospitals, clinics, surgical centers, pharmacies, insurance, and other healthcare settings. It’s a game-changer for patients and providers alike. |
TOP STORIES
PATENTS AND TECHNOLOGY
Owlet's Dream Sock Receives EU Medical Device Certification
by Sleep Review in May ‘24
Available over-the-counter, Dream Sock is designed for routine in-home monitoring of oxygen saturation and pulse rate in infants.
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
by The Washington Post in May ‘24
The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic. |
The Apple Watch just made history with a feature that can save your life
by Tom's Guide in May ‘24
The FDA has just approved the Apple Watch’s AFib feature in a watershed moment for digital health tech
TOP STORIES
HEALTHCARE TRANSACTIONS
Sandoz reaches agreement with Amgen over patent dispute
by Reuters in May ‘24
Swiss generic and biosimilar manufacturer Sandoz (SDZ.S), opens new tab said on Tuesday it had reached an agreement with U.S. drugmaker Amgen (AMGN.O), opens new tab resolving all patent litigation related to its U.S. denosumab biosimilars. |
Sight Sciences awarded $34m in Alcon patent infringement case
by GlobalData in May ‘24
Sight Sciences awarded $34m in Alcon patent infringement case. The judge is yet to rule on any potential enhancement of damages associated with the verdict.
RECENTLY
ISSUED PATENTS
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
by Globe Newswire in May ‘24
Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced an Issue Notification for the US continuation patent US 11,925,613 B2 and Canadian patent CA 3003149 titled “EFLORNITHINE AND SULINDAC, A FIXED DOSE COMBINATION FORMULATION”. |
Fullpower-AI Secures New Patents to Enhance Sleep with Artificial Intelligence
by Sleep Review in May ‘24
Fullpower-AI has secured five new patents from the US Patent and Trademark Office, enhancing its portfolio in sleep and wellness innovation. |
CURRENT PORTFOLIO AVAILABLE
FOR SALE
AND LICENSE WITH HIGH INTEREST
Imagine a putting green that seamlessly adapts to mimic the undulating landscapes of outdoor greens, right within the comfort of your home or office. This transformative innovation began as a grand commercial vision but has now been condensed into a compact 4’x8’ prototype, comprising two 4’x4’ modules. |
